Isothermal Nucleic Acid Amplification Technology Market by Product, Type, Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation

Description

List of Tables

The Global Isothermal Nucleic Acid Amplification Technology Market is forecasted to grow significantly, with a projected USD 3,770.42 million in 2023 at a CAGR of 13.48% and expected to reach a staggering USD 9,229.57 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Isothermal Nucleic Acid Amplification Technology Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Isothermal Nucleic Acid Amplification Technology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Assays, Kits, & Reagents and Systems. The Assays, Kits, & Reagents commanded largest market share of 63.33% in 2022, followed by Systems.

Based on Type, market is studied across Helicase-dependent Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence-based Amplification, Strand Displacement Amplification, and Transcription-mediated Amplification. The Loop-mediated Isothermal Amplification commanded largest market share of 25.78% in 2022, followed by Nucleic Acid Sequence-based Amplification.

Based on Application, market is studied across Blood Screening and Infectious Disease Diagnosis. The Infectious Disease Diagnosis is further studied across CT/NG, Hepatitis, HIV, and Influenza. The Infectious Disease Diagnosis commanded largest market share of 56.12% in 2022, followed by Blood Screening.

Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Reference Laboratories. The Reference Laboratories commanded largest market share of 52.23% in 2022, followed by Hospitals.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.33% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Isothermal Nucleic Acid Amplification Technology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Isothermal Nucleic Acid Amplification Technology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Isothermal Nucleic Acid Amplification Technology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Isothermal Nucleic Acid Amplification Technology Market?

4. What is the competitive strategic window for opportunities in the Global Isothermal Nucleic Acid Amplification Technology Market?

5. What are the technology trends and regulatory frameworks in the Global Isothermal Nucleic Acid Amplification Technology Market?

6. What is the market share of the leading vendors in the Global Isothermal Nucleic Acid Amplification Technology Market?

7. What modes and strategic moves are considered suitable for entering the Global Isothermal Nucleic Acid Amplification Technology Market?

Product Code: MRR-B9334AD6C2F6

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Isothermal Nucleic Acid Amplification Technology Market, by Product, 2022 vs 2030
4.3. Isothermal Nucleic Acid Amplification Technology Market, by Type, 2022 vs 2030
4.4. Isothermal Nucleic Acid Amplification Technology Market, by Application, 2022 vs 2030
4.5. Isothermal Nucleic Acid Amplification Technology Market, by End-User, 2022 vs 2030
4.6. Isothermal Nucleic Acid Amplification Technology Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of antimicrobial and infectious diseases worldwide
  - 5.1.1.2. Increasing adoption of INAAT for accurate & rapid testing results
  - 5.1.1.3. Development of miniaturized nucleic acid-based diagnostics
- 5.1.2. Restraints
  - 5.1.2.1. High cost of reagents and implementation of technology
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in isothermal nucleic acid amplification
  - 5.1.3.2. Increasing adoption of digital diagnostics and rising demand for point-of-care diagnostics solutions
- 5.1.4. Challenges
  - 5.1.4.1. Limitation of isothermal nucleic acid amplification technology
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Isothermal Nucleic Acid Amplification Technology Market, by Product

6.1. Introduction
6.2. Assays, Kits, & Reagents
6.3. Systems

7. Isothermal Nucleic Acid Amplification Technology Market, by Type

7.1. Introduction
7.2. Helicase-dependent Amplification
7.3. Loop-mediated Isothermal Amplification
7.4. Nucleic Acid Sequence-based Amplification
7.5. Strand Displacement Amplification
7.6. Transcription-mediated Amplification

8. Isothermal Nucleic Acid Amplification Technology Market, by Application

8.1. Introduction
8.2. Blood Screening
8.3. Infectious Disease Diagnosis
- 8.3.1. CT/NG
- 8.3.2. Hepatitis
- 8.3.3. HIV
- 8.3.4. Influenza

9. Isothermal Nucleic Acid Amplification Technology Market, by End-User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals
9.4. Reference Laboratories

10. Americas Isothermal Nucleic Acid Amplification Technology Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. Merger & Acquisition
  - 13.3.1.1. Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics
  - 13.3.1.2. Medix Biochemica Acquires German MDx Raw Materials Producer MyPols Biotec
- 13.3.2. Agreement, Collaboration, & Partnership
  - 13.3.2.1. Stilla Technologies and Atila BioSystems to Co-Develop High-Plex Digital PCR Kits for Oncology
  - 13.3.2.2. Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics
  - 13.3.2.3. WeTrade and Jiqing Biomedical partner to sell monkeypox tests
- 13.3.3. New Product Launch & Enhancement
  - 13.3.3.1. Recombinase Polymerase Amplification, or RPA, is the breakthrough, isothermal replacement to PCR
  - 13.3.3.2. Mawi iSWAB Microbiome-EL Enables Prime Discoveries' Development of Rapid Extraction-Less COVID Diagnostic Assay
  - 13.3.3.3. Thermo Fisher introduces two RT-LAMP tests to detect viral pathogens
- 13.3.4. Investment & Funding
  - 13.3.4.1. Polish biotech Genomtec raises EUR 2.9 million (USD 3.19 million) from share issue
  - 13.3.4.2. Ankur Capital invests in molecular diagnostic startup D-NOME

14. List of Company Mentioned

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing